The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer's disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.

WE ARE ON FACEBOOK

"Like" our facebook page to stay up to date on research findings and helpful information

JOIN OUR MAILING LIST!

Would you like to receive our Fall newsletter? Sign up here to receive our newsletter either in the mail or via email. We send out two newsletters a year to everyone on our mailing list and as well invitations to our yearly fall appreciation event.

Research Studies

Here are our research studies that are currently recruiting patients.

Title Sponsor
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4) ADCS/ Eli Lilly and Company

Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease *enrolling in MCI cohort only*

Biogen

DOD-ADNI: A Study of Brain Aging in Vietnam War Veterans

ADCS

Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

Merck

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

ATRI and Yale University

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

ATRI

An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)

Eli Lilly & Co

Check out our Research section for more information on how to participate in our clinical trials.

Make a Donation

For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.